RxDoctor Payments Data

Vishal Kothari, MD

Surgery · Omaha, NENPI 1083867170

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.1%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $3,090 and has fallen 58.3% since, to $1,289 in 2025.

$10,495in general payments, 2019–2025

Across 68 payments — averaging $154.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Davol Inc.$1K
  • Medical Device Business Services, Inc.$841
  • W. L. Gore & Associates, Inc.$795
  • BD$407
  • Covidien LP$306
  • plus $528 from 6 others
$31,784in research payments, 2019–2025

Across 5 payments — averaging $6356.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Davol Inc.$32K

What the payments were for

  • Speaking & faculty fees$4504%
  • Travel & lodging$4,42142%
  • Food & beverage$3,62435%
  • Education$2,00019%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,495 in reported general payments places this provider in the 80th percentile of 197 surgery providers in Nebraska.

See all surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$74,464
Medicare patients
141
Services billed
290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen23$278
Ondansetron OdtOndansetron13$106
Gabapentin25$38

Paid to pharmacies, not to this prescriber.

Other surgery in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →